iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.3100
+0.0160 (5.44%)
Jan 6, 2026, 4:00 PM EST - Market closed
iSpecimen Market Cap
iSpecimen has a market cap or net worth of $3.03 million as of January 6, 2026. Its market cap has decreased by -20.34% in one year.
Market Cap
3.03M
Enterprise Value
527.70K
1-Year Change
-20.34%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $3.03M, a decrease of -93.96%. That is a compound annual growth rate of -45.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 3.03M | 19.18% |
| Dec 31, 2025 | 2.54M | -0.56% |
| Dec 31, 2024 | 2.56M | -43.75% |
| Dec 29, 2023 | 4.54M | -62.95% |
| Dec 30, 2022 | 12.26M | -81.98% |
| Dec 31, 2021 | 68.07M | 35.75% |
| Jun 17, 2021 | 50.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 947.60B |
| Johnson & Johnson | 496.27B |
| AbbVie | 393.19B |
| UnitedHealth Group | 316.12B |
| AstraZeneca | 280.51B |
| Merck & Co. | 270.32B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |